Abstract
The ongoing 21st century SARS-CoV-2 pandemic has endangered global health and alarmed the scientific community at an unprecedented rate. Being a member of Coronaviridae family, the SARS-CoV-2 virus contains an enveloped, single-stranded, positive-sense RNA genome that typically affects the respiratory tract of mammals, including humans, leading to mild to severe respiratory tract infections. The ever costly and time-consuming process of drug discovery has led researchers to use in silico approaches to find potential drug candidates with reference to molecular and signaling pathways associated with the disease. Many studies on in silico tools are used to virtually screen small molecule databases for drug discovery against COVID-19.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
